US Bancorp
LEGN icon

US Bancorp’s Legend Biotech LEGN Stock Holding History

US Bancorp’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$254K Buy
8,778
+2,055
+31% +$55.4K ﹤0.01% 1978
2026
Q1 		$122K Buy
6,723
+5,916
+733% +$113K ﹤0.01% 2283
2025
Q4 		$17.5K Sell
807
-2,562
-76% -$73.4K ﹤0.01% 3129
2025
Q3 		$110K Sell
3,369
-684
-17% -$25.3K ﹤0.01% 2308
2025
Q2 		$144K Buy
4,053
+2,340
+137% +$75.8K ﹤0.01% 2230
2025
Q1 		$58.1K Sell
1,713
-3,099
-64% -$111K ﹤0.01% 2673
2024
Q4 		$157K Sell
4,812
-164
-3% -$6.79K ﹤0.01% 2154
2024
Q3 		$242K Sell
4,976
-6,279
-56% -$334K ﹤0.01% 1934
2024
Q2 		$498K Buy
11,255
+4,420
+65% +$204K ﹤0.01% 1490
2024
Q1 		$383K Buy
6,835
+293
+4% +$17.7K ﹤0.01% 1657
2023
Q4 		$394K Sell
6,542
-2,057
-24% -$130K ﹤0.01% 1643
2023
Q3 		$578K Sell
8,599
-421
-5% -$29.2K ﹤0.01% 1304
2023
Q2 		$623K Sell
9,020
-4,859
-35% -$317K ﹤0.01% 1277
2023
Q1 		$669K Buy
13,879
+811
+6% +$39.7K ﹤0.01% 1258
2022
Q4 		$652K Buy
13,068
+12,708
+3,530% +$616K ﹤0.01% 1269
2022
Q3 		$15K Buy
360
+118
+49% +$5.54K ﹤0.01% 3186
2022
Q2 		$13K Hold
242
– – ﹤0.01% 3273
2022
Q1 		$9K Buy
242
+160
+195% +$6.32K ﹤0.01% 3414
2021
Q4 		$4K Sell
82
-250
-75% -$12.7K ﹤0.01% 3721
2021
Q3 		$17K Buy
+332
New +$13.8K ﹤0.01% 3210

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

US Bancorp's LEGN Position: Q2 2026 in Review

US Bancorp increased its Legend Biotech (LEGN) stake by 31% in Q2 2026, buying an estimated $55.4K and bringing the position to 8,778 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

US Bancorp first reported a position in LEGN in Q3 2021 and has held it in 20 quarters since. The position peaked at $669K in Q1 2023. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • US Bancorp held 8,778 shares of Legend Biotech worth $254K as of Q2 2026.
  • US Bancorp bought 2,055 Legend Biotech shares in Q2 2026, an estimated $55.4K.
  • Legend Biotech made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1978 holding.
  • US Bancorp first reported a position in Legend Biotech in Q3 2021 and has held it in 20 quarters since.
  • US Bancorp's Legend Biotech position peaked at $669K in Q1 2023.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.